Authors: OSE L KASTELEIN JJP SCOTT R STEIN EA CAMPODONICO S ESCOBAR ID TATE AC CORSETTI L SHAHANE A MITCHEL YB MERCURI M

Citation: L. Ose et al., EFFICACY AND 6-MONTH SAFETY OF SIMVASTATIN 80 MG DAY - RESULTS FROM THE WORLDWIDE SIMVASTATIN EXPANDED DOSE PROGRAM (WSEDP)/, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 8(3), 1998, pp. 135-143

Authors: OSE L CORSETTI LA TATE AC SHAHANE A MITCHEL YB

Citation: L. Ose et al., EXTENDING THE DOSING RANGE FOR SIMVASTATIN - THE EFFICACY AND SAFETY OF SIMVASTATIN 80 MG D/, Atherosclerosis, 134(1-2), 1997, pp. 131-131

Authors: SWEANY AE SHAPIRO DR TATE AC GOLDBERG RB STEIN EA

Citation: Ae. Sweany et al., EFFECTS OF SIMVASTATIN VERSUS GEMFIBROZIL ON LIPIDS AND GLUCOSE CONTROL IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Clinical therapeutics, 17(2), 1995, pp. 186-203

Authors: SWEANY AE SHAPIRO DR TATE AC

Citation: Ae. Sweany et al., COMPARISON OF THE EFFICACY, SAFETY AND TOLERABILITY OF SIMVASTATIN AND PRAVASTATIN - REPLY, The American journal of cardiology, 73(9), 1994, pp. 723-724